| Targeting FcRn for the modulation of antibody dynamics ES Ward, SC Devanaboyina, RJ Ober Molecular immunology 67 (2), 131-141, 2015 | 92 | 2015 |
| The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics SC Devanaboyina, SM Lynch, RJ Ober, S Ram, D Kim, A Puig-Canto, ... MAbs 5 (6), 851-859, 2013 | 90 | 2013 |
| Prediction of IgE-binding epitopes by means of allergen surface comparison and correlation to cross-reactivity F Dall'Antonia, A Gieras, SC Devanaboyina, R Valenta, W Keller Journal of allergy and clinical immunology 128 (4), 872-879. e8, 2011 | 60 | 2011 |
| Engineered clearing agents for the selective depletion of antigen-specific antibodies SC Devanaboyina, P Khare, DK Challa, RJ Ober, ES Ward Nature communications 8 (1), 15314, 2017 | 41 | 2017 |
| Myelin oligodendrocyte glycoprotein-specific antibodies from multiple sclerosis patients exacerbate disease in a humanized mouse model P Khare, DK Challa, SC Devanaboyina, R Velmurugan, S Hughes, ... Journal of Autoimmunity 86, 104-115, 2018 | 37 | 2018 |
| The biodistribution of therapeutic proteins: Mechanism, implications for pharmacokinetics, and methods of evaluation KP Conner, SC Devanaboyina, VA Thomas, DA Rock Pharmacology & therapeutics 212, 107574, 2020 | 26 | 2020 |
| High‐resolution crystal structure and IgE recognition of the major grass pollen allergen Phl p 3 SC Devanaboyina, C Cornelius, C Lupinek, K Fauland, F Dall'Antonia, ... Allergy 69 (12), 1617-1628, 2014 | 21 | 2014 |
| Targeting Phosphatidylserine with Calcium-Dependent Protein–Drug Conjugates for the Treatment of Cancer R Li, S Chiguru, L Li, D Kim, R Velmurugan, D Kim, SC Devanaboyina, ... Molecular cancer therapeutics 17 (1), 169-182, 2018 | 17 | 2018 |
| Biophysical characterization of recombinant HIV-1 subtype C virus infectivity factor D Gallerano, SC Devanaboyina, I Swoboda, B Linhart, I Mittermann, ... Amino Acids 40, 981-989, 2011 | 14 | 2011 |
| Rapid depletion of “catch-and-release” anti-ASGR1 antibody in vivo SC Devanaboyina, P Li, EL LaGory, C Poon-Andersen, KD Cook, M Soto, ... Mabs 16 (1), 2383013, 2024 | | 2024 |
| Correlation of In Vitro Kinetic Stability to Preclinical In Vivo Pharmacokinetics for a Panel of Anti-PD-1 Monoclonal Antibody Interleukin 21 Mutein Immunocytokines KD Cook, T Tran, VA Thomas, SC Devanaboyina, DA Rock, JT Pearson Drug Metabolism and Disposition 52 (3), 228-235, 2024 | | 2024 |
| Structural characterisation of major Alternaria alternata allergen Alt a 1 K Prettler, I Swoboda, T Twaroch, S Devanaboyina, R Valenta, W Keller ALLERGY 66, 342-342, 2011 | | 2011 |
| Biophysical characterisation of the timothy grass pollen allergen Phl p 7 K Prettler, S Devanaboyina, K Westritschnig, R Valenta, W Keller ALLERGY 64, 249-249, 2009 | | 2009 |
| In silico prediction of conformational IgE epitopes based on structural and immunological data of Phl p 3 S Devanaboyina, C Lupinek, F Dall'Antonia, A Nandy, R Valenta, W Keller ALLERGY 64, 28-28, 2009 | | 2009 |
| High resolution x-ray structures of allergens for designing hypoallergenic derivatives for specific immunotherapy VSC Devanaboyina | | 2009 |
| Bacterially expressed and optimized recombinant Phl p 1 is immunobiochemically equivalent to natural Phl p 1. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1764 (11 …, 0 | | |
